The Cancer Research UK Oxford Centre, The Wellcome Centre for Human Genetics and Centre for Personalised Medicine are pleased to be collaborating in the creation of a 2 day pilot workshop on, 'Genomics in Cancer Research’. The workshop will be held at The Wellcome Centre for Human Genetics on Monday 3rd December and Tuesday 4th December 2018. The event is free to attend and therefore places are limited. You must be a member of the CRUK Oxford Centre to attend prior to registration, in order to do this please contact firstname.lastname@example.org ASAP who will be able to assist in this process. Please register for your place now here.
This one-day conference is designed to show the breadth of multidisciplinary research employed to strengthen health systems in low- and middle-income countries. Key-note speakers will introduce participants to a range of issues from across the spectrum of health systems research. An opportunity to find collaboration opportunities, and showcase your work by submitting an abstract. Thursday 6th December at Saint Antony's College, Oxford.
The role of biostatisticians in clinical research is to contribute to trial design, by calculating sample size for example, and to help draw correct conclusions from the data, discriminating important information from noise. They are instrumental in the translation of a practical problem into a statistical model, and the translation of the result into practice.
Many congratulations to Prof Ling-Pei Ho, who was awarded £872K to study an exciting new research avenue in lung fibrosis. Prof Ho will lead a network of collaborators from King's College London, Newcastle and the Gurdon Institute in Cambridge in this endeavour. The programme will take advantage of advanced technologies such as single cell RNA sequencing, mass cytometry, and gene editing. The team aims to build a detailed view of how the immune system impacts on the regeneration potential of the lungs following injury.
Funding will be provided to the University of Oxford through the Government’s Industrial Strategy Challenge Fund by as part of a £50 million investment to establish a network of digital pathology, imaging and AI centres, to drive innovation in the use of AI for improved diagnosis and delivery of precision treatments. Oxford is to be home to one of the five new technology centres across the country, and is also a collaborator in two of the other centres, with local activities integrated within the Big Data Institute.
Pneumothorax is a common condition which can affect anyone where air leaks from the lung and causes lung collapse. Researchers from the Clinical Trials Support Unit and Oxford Respiratory Trials Unit have conducted the world’s largest ever analysis of pneumothorax (over 170,000 cases) using hospital records, and demonstrated that this condition is increasing. The reasons for this are not clear, but provide important data on trends in this disease, and highlight the need for further research in to treatment and prevention
Thursday 15 November 2018 , 1 - 2 pm
Lecture Theatre 1
Radiology: "The National Consortium of Intelligent Medical Imaging is open for business", Prof Fergus Gleeson
Psychological Medicine: "STROKE (I63.3) OR NOT (F44.4)? What is WDZZ22?", Dr Luke Solomons and Dr Ursula Schulz
Chair: Prof Hugh Watkins